US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.5474
  • -0.0345-5.93%
Close Nov 4 15:58 ET
2.75MMarket Cap-99P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-41.63%-3.11M
-41.15%-5.77M
20.24%-15.28M
-6.51%-4.58M
11.09%-4.42M
57.26%-2.19M
14.07%-4.09M
-25.84%-19.16M
-8.64%-4.3M
13.56%-4.97M
Net income from continuing operations
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
Operating gains losses
----
----
-50.00%1K
----
----
----
----
0.00%2K
----
----
Depreciation and amortization
2.99%241K
4.80%240K
4.79%941K
6.19%240K
3.48%238K
1.30%234K
8.53%229K
14.98%898K
10.45%226K
17.32%230K
Other non cash items
-227.59%-37K
-59.09%18K
-78.69%107K
-67.92%17K
-64.58%17K
-40.82%29K
-87.50%44K
-65.38%502K
-31.85%53K
-96.20%48K
Change In working capital
-40.82%1.42M
-906.72%-1.2M
134.81%1.67M
65.22%-795K
115.43%185K
440.83%2.4M
80.20%-119K
-411.99%-4.79M
-265.31%-2.29M
16.37%-1.2M
-Change in prepaid assets
-35.18%1.21M
-116.24%-393K
194.90%3.98M
99.15%-13K
54.31%-286K
185.73%1.86M
1,883.61%2.42M
-410.89%-4.2M
-219.51%-1.52M
62.32%-626K
-Change in payables and accrued expense
-44.76%369K
72.95%-651K
-2,336.11%-1.75M
0.79%-631K
240.64%616K
-58.20%668K
-303.86%-2.41M
-111.16%-72K
-371.37%-636K
-227.81%-438K
-Change in other current liabilities
-17.91%-158K
-16.67%-154K
-8.08%-562K
-17.05%-151K
-7.41%-145K
-3.88%-134K
-3.94%-132K
-13.04%-520K
-3.89%-129K
-17.38%-135K
Cash from discontinued investing activities
Operating cash flow
-41.63%-3.11M
-41.15%-5.77M
20.24%-15.28M
-6.51%-4.58M
11.09%-4.42M
57.26%-2.19M
14.07%-4.09M
-25.84%-19.16M
-8.64%-4.3M
13.56%-4.97M
Investing cash flow
Cash flow from continuing investing activities
-147.40%-2.94M
-33.33%2M
171.52%13.24M
7,147.62%2.96M
-81.15%1.08M
263.45%6.2M
1.32%3M
-70.92%4.88M
-174.14%-42K
2,269.23%5.75M
Net PPE purchase and sale
----
----
75.56%-218K
--0
93.60%-16K
----
----
-243.08%-892K
-17.28%-42K
-11.51%-250K
Net investment purchase and sale
-145.91%-2.94M
-33.33%2M
133.32%13.46M
--2.96M
-81.67%1.1M
271.26%6.4M
-14.43%3M
-66.12%5.77M
--0
1,185.12%6M
Cash from discontinued investing activities
Investing cash flow
-147.40%-2.94M
-33.33%2M
171.52%13.24M
7,147.62%2.96M
-81.15%1.08M
263.45%6.2M
1.32%3M
-70.92%4.88M
-174.14%-42K
2,269.23%5.75M
Financing cash flow
Cash flow from continuing financing activities
919,000.00%9.19M
1,425.00%53K
-108.86%-7K
80.00%-1K
66.67%-1K
83.33%-1K
-104.30%-4K
-98.87%79K
-160.02%-5K
63.96%-3K
Net issuance payments of debt
0.00%-1K
75.00%-1K
65.00%-7K
80.00%-1K
66.67%-1K
83.33%-1K
33.33%-4K
33.33%-20K
9.76%-5K
63.96%-3K
Net common stock issuance
--9.19M
--54K
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
-93.00%99K
--0
--0
Cash from discontinued financing activities
Financing cash flow
919,000.00%9.19M
1,425.00%53K
-108.86%-7K
80.00%-1K
66.67%-1K
83.33%-1K
-104.30%-4K
-98.87%79K
-160.02%-5K
63.96%-3K
Net cash flow
Beginning cash position
-77.94%1.32M
-28.86%5.04M
-66.73%7.08M
-41.74%6.66M
-6.16%9.99M
-69.41%5.99M
-66.73%7.08M
66.67%21.28M
-54.61%11.43M
-65.30%10.65M
Current changes in cash
-21.45%3.15M
-240.60%-3.72M
85.61%-2.04M
62.72%-1.62M
-529.34%-3.34M
144.84%4M
35.90%-1.09M
-266.82%-14.2M
-11.66%-4.35M
114.09%777K
End cash Position
-55.31%4.47M
-77.94%1.32M
-28.86%5.04M
-28.86%5.04M
-41.74%6.66M
-6.16%9.99M
-69.41%5.99M
-66.73%7.08M
-66.73%7.08M
-54.61%11.43M
Free cash flow
-29.69%-3.11M
-41.15%-5.77M
22.71%-15.5M
-5.48%-4.58M
15.04%-4.44M
53.82%-2.4M
22.90%-4.09M
-29.48%-20.05M
-8.71%-4.34M
12.62%-5.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -41.63%-3.11M-41.15%-5.77M20.24%-15.28M-6.51%-4.58M11.09%-4.42M57.26%-2.19M14.07%-4.09M-25.84%-19.16M-8.64%-4.3M13.56%-4.97M
Net income from continuing operations 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M
Operating gains losses ---------50.00%1K----------------0.00%2K--------
Depreciation and amortization 2.99%241K4.80%240K4.79%941K6.19%240K3.48%238K1.30%234K8.53%229K14.98%898K10.45%226K17.32%230K
Other non cash items -227.59%-37K-59.09%18K-78.69%107K-67.92%17K-64.58%17K-40.82%29K-87.50%44K-65.38%502K-31.85%53K-96.20%48K
Change In working capital -40.82%1.42M-906.72%-1.2M134.81%1.67M65.22%-795K115.43%185K440.83%2.4M80.20%-119K-411.99%-4.79M-265.31%-2.29M16.37%-1.2M
-Change in prepaid assets -35.18%1.21M-116.24%-393K194.90%3.98M99.15%-13K54.31%-286K185.73%1.86M1,883.61%2.42M-410.89%-4.2M-219.51%-1.52M62.32%-626K
-Change in payables and accrued expense -44.76%369K72.95%-651K-2,336.11%-1.75M0.79%-631K240.64%616K-58.20%668K-303.86%-2.41M-111.16%-72K-371.37%-636K-227.81%-438K
-Change in other current liabilities -17.91%-158K-16.67%-154K-8.08%-562K-17.05%-151K-7.41%-145K-3.88%-134K-3.94%-132K-13.04%-520K-3.89%-129K-17.38%-135K
Cash from discontinued investing activities
Operating cash flow -41.63%-3.11M-41.15%-5.77M20.24%-15.28M-6.51%-4.58M11.09%-4.42M57.26%-2.19M14.07%-4.09M-25.84%-19.16M-8.64%-4.3M13.56%-4.97M
Investing cash flow
Cash flow from continuing investing activities -147.40%-2.94M-33.33%2M171.52%13.24M7,147.62%2.96M-81.15%1.08M263.45%6.2M1.32%3M-70.92%4.88M-174.14%-42K2,269.23%5.75M
Net PPE purchase and sale --------75.56%-218K--093.60%-16K---------243.08%-892K-17.28%-42K-11.51%-250K
Net investment purchase and sale -145.91%-2.94M-33.33%2M133.32%13.46M--2.96M-81.67%1.1M271.26%6.4M-14.43%3M-66.12%5.77M--01,185.12%6M
Cash from discontinued investing activities
Investing cash flow -147.40%-2.94M-33.33%2M171.52%13.24M7,147.62%2.96M-81.15%1.08M263.45%6.2M1.32%3M-70.92%4.88M-174.14%-42K2,269.23%5.75M
Financing cash flow
Cash flow from continuing financing activities 919,000.00%9.19M1,425.00%53K-108.86%-7K80.00%-1K66.67%-1K83.33%-1K-104.30%-4K-98.87%79K-160.02%-5K63.96%-3K
Net issuance payments of debt 0.00%-1K75.00%-1K65.00%-7K80.00%-1K66.67%-1K83.33%-1K33.33%-4K33.33%-20K9.76%-5K63.96%-3K
Net common stock issuance --9.19M--54K--------------0--0------------
Proceeds from stock option exercised by employees ----------0--0-------------93.00%99K--0--0
Cash from discontinued financing activities
Financing cash flow 919,000.00%9.19M1,425.00%53K-108.86%-7K80.00%-1K66.67%-1K83.33%-1K-104.30%-4K-98.87%79K-160.02%-5K63.96%-3K
Net cash flow
Beginning cash position -77.94%1.32M-28.86%5.04M-66.73%7.08M-41.74%6.66M-6.16%9.99M-69.41%5.99M-66.73%7.08M66.67%21.28M-54.61%11.43M-65.30%10.65M
Current changes in cash -21.45%3.15M-240.60%-3.72M85.61%-2.04M62.72%-1.62M-529.34%-3.34M144.84%4M35.90%-1.09M-266.82%-14.2M-11.66%-4.35M114.09%777K
End cash Position -55.31%4.47M-77.94%1.32M-28.86%5.04M-28.86%5.04M-41.74%6.66M-6.16%9.99M-69.41%5.99M-66.73%7.08M-66.73%7.08M-54.61%11.43M
Free cash flow -29.69%-3.11M-41.15%-5.77M22.71%-15.5M-5.48%-4.58M15.04%-4.44M53.82%-2.4M22.90%-4.09M-29.48%-20.05M-8.71%-4.34M12.62%-5.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data